Evidence map›Paper›PMID 37476046›Full record

ArticleRSC advances2023

Metal-free C-3 selective C(sp

Kai Wang, Xiaoxue Du, Pengfei Zhang, Zhenjiang Wei, Xian-Ting Cao

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kai WangCollege of Medical Engineering & the Key Laboratory for Medical Functional Nanomaterials, Jining Medical University Jining 272067 China chemcxt@mail.jnmc.edu.cn.
Xiaoxue DuCollege of Medical Engineering & the Key Laboratory for Medical Functional Nanomaterials, Jining Medical University Jining 272067 China chemcxt@mail.jnmc.edu.cn.
Pengfei ZhangCollege of Material, Chemistry and Chemical Engineering, Key Laboratory of Organosilicon Chemistry and Material Technology, Ministry of Education, Hangzhou Normal University Hangzhou 311121 China.ORCID https://orcid.org/0000-0001-9859-0237
Zhenjiang WeiDepartment of Pharmaceutical Engineering, Shandong Medicine Technician College Taian 271016 China tianyiwzj@126.com.
Xian-Ting CaoCollege of Medical Engineering & the Key Laboratory for Medical Functional Nanomaterials, Jining Medical University Jining 272067 China chemcxt@mail.jnmc.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A general and straightforward method for the regioselective construction of C-3 heteroaryl-containing imidazo[1,2-

Identifiers

PMID37476046
PMCPMC10355276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.